Search Results - "NISHIYAMA, O."

Refine Results
  1. 1

    Risk factors of acute exacerbation of idiopathic pulmonary fibrosis by Kondoh, Y, Taniguchi, H, Katsuta, T, Kataoka, K, Kimura, T, Nishiyama, O, Sakamoto, K, Johkoh, T, Nishimura, M, Ono, K, Kitaichi, M

    “…Although acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a well known clinical condition, predicting risk factors remain unknown. We…”
    Get full text
    Journal Article
  2. 2

    A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis by NISHIYAMA, O, TANIGUCHI, H, KONDOH, Y, KIMURA, T, KATO, K, KATAOKA, K, OGAWA, T, WATANABE, F, ARIZONO, S

    Published in The European respiratory journal (01-11-2010)
    “…The prognosis in idiopathic pulmonary fibrosis (IPF) is poor. No therapy has been shown to prolong survival. The objective of this study was to examine the…”
    Get full text
    Journal Article
  3. 3

    Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? by Nishiyama, O., Taniguchi, H., Kondoh, Y., Kimura, T., Ogawa, T., Watanabe, F., Nishimura, K.

    Published in Respiratory medicine (01-04-2005)
    “…The prognosis of patients with idiopathic pulmonary fibrosis (IPF) is generally considered to be poor. As the disease progresses, patients invariably become…”
    Get full text
    Journal Article
  4. 4

    Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia by Kondoh, Y, Taniguchi, H, Yokoi, T, Nishiyama, O, Ohishi, T, Kato, T, Suzuki, K, Suzuki, R

    Published in The European respiratory journal (01-03-2005)
    “…The present study compared the efficacy of cyclophosphamide combined with low-dose prednisolone in the treatment of idiopathic pulmonary fibrosis (IPF) with…”
    Get full text
    Journal Article
  5. 5

    Health-related quality of life does not predict mortality in idiopathic pulmonary fibrosis by Nishiyama, O, Taniguchi, H, Kondoh, Y, Kimura, T, Kataoka, K, Nishimura, K, Ogawa, T, Watanabe, F, Arizono, S, Tohda, Y

    “…Although health-related quality of life (HRQL) has recently been considered to be an important outcome in clinical trials of idiopathic pulmonary fibrosis…”
    Get full text
    Journal Article
  6. 6

    Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma by Kotani, H., Kishi, R., Mouri, A., Sashio, T., Shindo, J., Shiraki, A., Hiramatsu, T., Iwata, S., Taniguchi, H., Nishiyama, O., Iwata, M., Suzuki, R., Gonda, H., Niwa, T., Kondo, M., Hasegawa, Y., Kume, H., Noda, Y.

    “…Summary What is known and Objective:  Montelukast, a cysteinyl leukotriene receptor 1 antagonist, is safe and efficacious in patients with asthma. The…”
    Get full text
    Journal Article
  7. 7

    Factors in Maintaining Long-Term Improvements in Health-Related Quality of Life after Pulmonary Rehabilitation for COPD by O. Nishiyama, Taniguchi, H., Y. Kondoh, Kimura, T., Ogawa, T., F. Watanabe, S. Arizono

    Published in Quality of life research (01-12-2005)
    “…The purpose of this study was to reveal predictors for the long-term effects of pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD)…”
    Get full text
    Journal Article
  8. 8

    The effectiveness of the Visual Analogue Scale 8 in measuring health-related quality of life for COPD patients by NISHIYAMA, O., TANIGUCHI, H., KONDOH, Y., NISHIMURA, K., SUZUKI, R., TAKAGI, K., YAMAKI, K.

    Published in Respiratory medicine (01-12-2000)
    “…The Visual Analogue Scale 8 (VAS8), consisting of eight linear scales, has been developed to measure health-related quality of life (HRQoL) in chronic…”
    Get full text
    Journal Article Conference Proceeding
  9. 9
  10. 10
  11. 11
  12. 12

    C73 NEW MECHANISMS AND THERAPIES IN COPD: Role Of Allosteric Gpcr Modulation In Cross Talk Between â2-Adrenergic And Muscarinic Receptors In Airway Smooth Muscle by Kume, H, Nishiyama, O, Isoya, T, Higashimoto, Y, Tohda, Y

    “…Corresponding author's email: hkume@med.kindai.ac.jp Rationale: Brochodilators, such as long acting ß2-adrenergic receptor agonists (LABAs) and muscarinic…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis by Nishiyama, Osamu, Taniguchi, Hiroyuki, Kondoh, Yasuhiro, Kimura, Tomoki, Ogawa, Tomoya, Watanabe, Fumiko, Arizono, Shinichi

    Published in Chest (01-06-2005)
    “…In COPD, it has been shown that peripheral muscle dysfunction is a factor determining exercise intolerance. We examined the hypothesis that exercise capacity…”
    Get more information
    Journal Article